Minocycline-13C-d3

Introducing Minocycline-13C-d3, a highly specialized and meticulously crafted deuterated active pharmaceutical ingredient (API) for research purposes. This compound, with the CAS number 10118-90-8 and the reference number 4Z-M-342, is a valuable asset for scientists and researchers exploring the frontiers of pharmaceutical development and drug discovery.

Minocycline-13C-d3 is a deuterated derivative of the well-known antibiotic minocycline, a tetracycline-class drug widely used in the treatment of various bacterial infections. The strategic incorporation of 13C and deuterium (D) atoms into the molecular structure of this compound offers unique advantages for researchers, enabling them to delve deeper into the pharmacokinetics, metabolism, and mechanism of action of minocycline-based therapies.

Unraveling the Power of Deuteration

The presence of 13C and deuterium atoms in Minocycline-13C-d3 introduces subtle yet impactful changes to the compound's physical and chemical properties. These isotopic substitutions can lead to altered metabolic pathways, modified enzyme kinetics, and enhanced stability, providing researchers with a powerful tool to investigate the behavior and fate of minocycline in biological systems.

By leveraging the unique properties of Minocycline-13C-d3, researchers can gain valuable insights into the drug's absorption, distribution, metabolism, and excretion (ADME) characteristics. This knowledge can inform the development of more effective and safer minocycline-based treatments, ultimately benefiting patients and advancing the field of antimicrobial therapeutics.

Versatile Applications in Research

• Pharmacokinetic Studies: Minocycline-13C-d3 serves as a valuable tracer compound, enabling researchers to track the drug's fate and distribution within the body through advanced analytical techniques, such as mass spectrometry. This information is crucial for optimizing dosing regimens and improving the overall efficacy of minocycline-based therapies.
• Metabolic Profiling: The deuterium labels in Minocycline-13C-d3 can help researchers identify and characterize the metabolic pathways of minocycline, shedding light on the formation of active metabolites and potential drug-drug interactions. This knowledge is essential for understanding the drug's mechanism of action and potential side effects.
• Stability and Degradation Studies: The enhanced stability of Minocycline-13C-d3 due to the deuterium substitutions can provide researchers with a more reliable model for investigating the compound's behavior under various storage conditions, formulation strategies, and environmental factors. This information is crucial for ensuring the quality, potency, and shelf-life of minocycline-based pharmaceutical products.

Rigorous Quality and Safety Standards

Minocycline-13C-d3 is meticulously produced to meet the highest standards of purity and quality, ensuring reliable and reproducible results in research applications. With a molecular weight of 461.49 g/mol and a chemical formula of C23H24N3O7D3, this compound is a testament to the expertise and dedication of our team.

It is important to note that Minocycline-13C-d3 is intended for laboratory use only and is not meant for human consumption. Appropriate safety precautions should be taken when handling this product, including the use of personal protective equipment (PPE) and working in a well-ventilated area.

Unlock the Potential of Minocycline-13C-d3

Embark on your research journey with Minocycline-13C-d3 and unlock the vast potential of this versatile deuterated API. Leverage its unique properties to uncover new insights, optimize drug development processes, and contribute to the advancement of antimicrobial therapeutics. Consult our team of experts for additional information, technical support, and access to a wealth of resources to guide your research endeav